Valuation: biote Corp.

Market Cap 69.16M 60.5M 55.79M 51.62M 97.97M 6.6B 99.61M 668M 262M 3.24B 260M 254M 11.23B P/E 2026 *
10.7x
P/E 2027 * 7.77x
Enterprise Value 155M 136M 125M 116M 220M 14.8B 223M 1.5B 587M 7.27B 582M 569M 25.17B EV / Sales 2026 *
0.81x
EV / Sales 2027 * 0.69x
Free-Float
85.15%
Yield 2026 *
-
Yield 2027 * -
1 day+0.88%
1 week+5.07%
Current month+20.63%
1 month+3.17%
3 months+50.99%
6 months-11.63%
Current year-12.31%
1 week 2.14
Extreme 2.14
2.34
1 month 1.63
Extreme 1.63
2.5
Current year 1.27
Extreme 1.27
2.68
1 year 1.27
Extreme 1.27
4.75
3 years 1.27
Extreme 1.27
8.44
5 years 1.27
Extreme 1.27
10.52
10 years 1.27
Extreme 1.27
10.52
Manager TitleAgeSince
Chief Executive Officer 49 2026-06-11
Chief Tech/Sci/R&D Officer 69 2024-02-29
Sales & Marketing - -
Director TitleAgeSince
Chairman 61 2022-04-30
Director/Board Member 51 2022-04-30
Director/Board Member 63 2022-04-30
Date Insider Type Main position Quantity % Market Cap.
06-11Free

Chief Executive Officer

206,746 0.6816%
06-07Free

Chief Executive Officer

130,000 0.4286%
06-07Free

Chairman

114,157 0.3764%
Change 5-day change 1-year change 3-year change Capi.($)
+0.88%+5.07%-44.66%-64.38% 69.16M
+1.10%-2.75%-21.03%+23.33% 143M
-0.68%-11.50%-32.79%-90.06% 100M
+4.17%+4.17%+6.84%+8.70% 59.12M
+0.73%-0.10%-61.29%-63.21% 50.88M
Average +1.24%-1.67%-30.59%-37.12% 84.41M
Weighted average by Cap. +1.03%-3.14%-28.64%-30.41%

Financials

2026 *2027 *
Net sales 191M 167M 154M 142M 270M 18.21B 275M 1.84B 723M 8.94B 716M 701M 30.98B 204M 178M 164M 152M 288M 19.43B 293M 1.97B 771M 9.54B 764M 748M 33.05B
Net income 7.74M 6.77M 6.24M 5.78M 10.96M 739M 11.15M 74.75M 29.3M 363M 29.05M 28.42M 1.26B 10.67M 9.34M 8.61M 7.97M 15.12M 1.02B 15.37M 103M 40.41M 500M 40.06M 39.19M 1.73B
Net Debt 85.86M 75.11M 69.26M 64.08M 122M 8.2B 124M 829M 325M 4.02B 322M 315M 13.94B 71.8M 62.81M 57.92M 53.59M 102M 6.85B 103M 694M 272M 3.37B 270M 264M 11.66B
Logo biote Corp.
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Employees
223
Date Price Change Volume
26-07-09 US$2.280 +0.88% 155,529
26-07-08 US$2.260 +0.44% 142,208
26-07-07 US$2.250 -1.32% 245,260
26-07-06 US$2.280 +5.07% 260,332
26-07-02 US$2.170 +9.05% 265,157
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.280USD
Average target price
2.986USD
Spread / Average Target
+30.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BTMD Stock